Delivery Order SPE2DB24D1021-SPE2DB25FFAGL
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loestrin 21 1-20 tablets (21-count packages) under a firm fixed-price contract with a ceiling value of $3,580.26. This non-competitive delivery order is expected to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,790.10 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract, issued under firm fixed-price terms with no set-aside designation, covers the supply of Loestrin 21 1-20 tablets in a quantity of 21 units. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $14,675.22 to AmerisourceBergen Drug Corp for the supply of Loestrin FE 1-20 tablets in 28-count packages. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of July 30, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 29, 2025, valued at $2,132.46 for the supply of Lo Loestrin Fe 1-10 Tablet 28s. This firm fixed price contract, which is set to be completed by September 2, 2025, was competitively awarded without set-aside restrictions to support the Defense Logistics Agency's Medical Supply Chain operations. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a $3,400.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LOESTRIN FE 1-20 tablets (28-count packaging) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a non-set-aside, competitively awarded contract executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This competitively awarded, non-set-aside contract carries a ceiling value of $11,276.65 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Loestrin 21 1-20 Tablet in quantities of 21 tablets, with a contract ceiling value of $2,983.50 and a firm fixed price structure. The contract is non-set-aside and represents a competitive award for pharmaceutical supply. This delivery order is completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAGLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,248.51 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-tablet supply) on September 4, 2025, with completion scheduled for September 5, 2025. This competitive award, issued without set-aside designation, represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems. This delivery order exemplifies the routine pharmaceutical procurement operations conducted through AmerisourceBergen's prime vendor contract, which authorizes the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The contract vehicle enables the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems to procure essential medications efficiently. As a major pharmaceutical distributor with demonstrated capability to meet federal requirements through open competition, AmerisourceBergen maintains an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, supporting the Defense Logistics Agency's mission to ensure adequate medical supply chain support for the Department of Defense and related federal health programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/4/25 |